MorphoSys Announces Expansion of Collaboration With Novartis
June 23, 2006 15:49 ET
|
MorphoSys AG
MARTINSRIED, Germany, June 23, 2006 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) announced an expansion of its existing therapeutic antibody collaboration with...
MorphoSys Announces Re-election of Supervisory Board Members
May 18, 2006 02:13 ET
|
MorphoSys AG
MARTINSRIED, Germany, May 18, 2006 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) announced today that at the Company's annual shareholder meeting on Wednesday, May 17,...
MorphoSys Reports First Quarter 2006 Results
April 28, 2006 02:06 ET
|
MorphoSys AG
MARTINSRIED, Germany, April 28, 2006 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) today reported financial results according to IFRS for its first quarter ended March...
Invitation to Q1 2006 Conference Call of MorphoSys AG on April 28, 2006
April 21, 2006 11:42 ET
|
MorphoSys AG
MARTINSRIED, Germany, April 21, 2006 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) will publish its First Quarter 2006 results on April 28, 2006 at 7:30 a.m. CET.
At...
MorphoSys Achieves Fourth Therapeutic Milestone in Centocor Collaboration
February 28, 2006 01:56 ET
|
MorphoSys AG
MARTINSRIED, Germany, Feb. 28, 2006 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard:MOR) today announced the achievement of a fourth therapeutic milestone within the scope of its...
MorphoSys AG Reports Financial Results for Fiscal Year 2005
February 24, 2006 01:43 ET
|
MorphoSys AG
MARTINSRIED, Germany, Feb. 24, 2006 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard:TecDAX) today announced its financial results according to International Financial Reporting Standards...
MorphoSys Reports Preliminary Financial Results for 2005
February 03, 2006 07:08 ET
|
MorphoSys AG
MARTINSRIED, Germany, Feb. 3, 2006 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment, TecDAX) today reported preliminary unaudited financial results according to International...
MorphoSys AG -- Invitation to Conference Call Regarding Acquisition of Serotec Group
January 12, 2006 02:36 ET
|
MorphoSys AG
MARTINSRIED, Germany, Jan. 12, 2006 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment, TecDAX) will host a public conference call to discuss the acquisition of the Serotec Goup....
MorphoSys and Chemicon International Enter into Worldwide Licensing Agreement for Research Antibodies
January 10, 2006 02:08 ET
|
MorphoSys AG
MARTINSRIED, Germany, Jan. 10, 2006 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) and Chemicon International, Inc., a subsidiary of Serologicals Corporation (Nasdaq:SERO)...
MorphoSys Establishes American Depository Receipt Level One Program in USA
January 10, 2006 01:54 ET
|
MorphoSys AG
MARTINSRIED, Germany, Jan. 10, 2006 (PRIMEZONE) -- Morphosys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) today announced the launch of a sponsored ADR (American Depository Receipt) Program...